Siddiqui T, Durkin W J, Conley N S, Doughney K B, Favis G R, Weiss R, Smith A E
Regional Oncology Center, Daytona Beach.
J Fla Med Assoc. 1994 Jul;81(7):475-7.
Survival of older patients with acute nonlymphocytic leukemia treated with chemotherapy was compared with those given only supportive care. The treated group was younger and had better survival. The benefits which measure in months must be balanced against socioeconomic cost, toxicity of therapy, patient wishes, and evolving information about the standards of management in the older leukemia patient.
对接受化疗的老年急性非淋巴细胞白血病患者与仅接受支持性治疗的患者的生存率进行了比较。接受治疗的组年龄较小且生存率更高。以月为单位衡量的益处必须与社会经济成本、治疗毒性、患者意愿以及关于老年白血病患者管理标准的不断变化的信息相权衡。
